NCT00257348View on ClinicalTrials.gov

Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Cervical Cancer

Interventions

DRUG

Capecitabine

DRUG

Docetaxel

Trial Locations (1)

92868

Chao Family Comprehensive Cancer Center, Orange

Sponsors

Collaborators (1)

Aventis Pharmaceuticals

All Listed Sponsors

collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

University of California, Irvine

OTHER